Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121811935 | 12181193 | 5 | F | 201601 | 20160915 | 20160315 | 20160920 | PER | US-CELGENEUS-USA-2016032324 | CELGENE | 52.65 | YR | M | Y | 93.07000 | KG | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121811935 | 12181193 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A21038E | 21880 | 25 | MG | CAPSULES | QD | ||||
| 121811935 | 12181193 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 4 MILLIGRAM | Y | U | A21038E | 21880 | 15 | MG | CAPSULES | QD | |||
| 121811935 | 12181193 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A21038E | 21880 | 25 | MG | CAPSULES | |||||
| 121811935 | 12181193 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A21038E | 21880 | 15 | MG | CAPSULES | |||||
| 121811935 | 12181193 | 5 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A21038E | 21880 | 15 | MG | CAPSULES | |||||
| 121811935 | 12181193 | 6 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 121811935 | 12181193 | 7 | SS | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 121811935 | 12181193 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121811935 | 12181193 | 9 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | 4 | MG | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121811935 | 12181193 | 1 | Plasma cell myeloma |
| 121811935 | 12181193 | 6 | Product used for unknown indication |
| 121811935 | 12181193 | 7 | Product used for unknown indication |
| 121811935 | 12181193 | 8 | Product used for unknown indication |
| 121811935 | 12181193 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121811935 | 12181193 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121811935 | 12181193 | Ageusia | |
| 121811935 | 12181193 | Constipation | |
| 121811935 | 12181193 | Fatigue | |
| 121811935 | 12181193 | Hypoaesthesia | |
| 121811935 | 12181193 | Neutropenia | |
| 121811935 | 12181193 | Paraesthesia | |
| 121811935 | 12181193 | Pneumonia | |
| 121811935 | 12181193 | Pruritus | |
| 121811935 | 12181193 | Vision blurred | |
| 121811935 | 12181193 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121811935 | 12181193 | 1 | 200806 | 0 | ||
| 121811935 | 12181193 | 2 | 200809 | 0 | ||
| 121811935 | 12181193 | 3 | 201601 | 0 | ||
| 121811935 | 12181193 | 4 | 201604 | 0 | ||
| 121811935 | 12181193 | 5 | 201608 | 0 |